SLDB – solid biosciences inc. (US:NASDAQ)
Stock Stats
News
Solid Biosciences to Participate at Upcoming Investor Conferences
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Solid Biosciences Inc. (NASDAQ: SLDB) had its price target lowered by analysts at JPMorgan Chase & Co. from $12.00 to $11.00. They now have an "overweight" rating on the stock.
Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Solid Biosciences Inc. (NASDAQ: SLDB) had its price target raised by analysts at HC Wainwright from $16.00 to $20.00. They now have a "buy" rating on the stock.
Form SCHEDULE 13G/A Solid Biosciences Inc. Filed by: Invus Global Management, LLC
Form PRE 14A Solid Biosciences Inc. For: Jun 12
Form 4 Solid Biosciences Inc. For: Apr 06 Filed by: SMITH IAN F
Form EFFECT Solid Biosciences Inc.
Form EFFECT Solid Biosciences Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.